$CLBS News Article - Caladrius Biosciences Receives Advanced Therapy Medicinal Product Classification for CLBS12, its CD34+ Cell Therapy for Critical Limb Ischemia https://marketwirenews.com/news-releases/cala...09789.html
My Twitter: WhyteStocks